AXSM Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 609 min ago

@ $74.81

Wydano: 6 geg. 2024 @ 17:40

Zwrot: 1.51%

Poprzedni sygnał: geg. 3 - 22:47

Poprzedni sygnał: Sprzedaż

Zwrot: -0.55 %

Live Chart Being Loaded With Signals

Commentary (6 geg. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.11% compare to its pairs and should correct upwards.

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States...

Stats
Dzisiejszy wolumen	800 966
Średni wolumen	723 995
Kapitalizacja rynkowa	3.60B
EPS	$0 ( 2024-02-20 )
Następna data zysków	( $-1.200 ) 2024-06-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-14.41
ATR14	$4.67 (6.16%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Jacobson Mark L.	Buy	24 662	Common Stock
2024-04-01	Jacobson Mark L.	Sell	24 662	Stock Option (Right to Buy)
2024-04-01	Jacobson Mark L.	Sell	24 662	Common Stock
2024-03-14	Jeffs Roger	Buy	16 976	Common Stock
2024-03-14	Jeffs Roger	Buy	13 000	Common Stock

INSIDER POWER
55.27
Last 99 transactions
Buy: 2 269 939 \| Sell: 680 650

Korelacja (AI algo v.1.1b): Undervalued: 0.11% $75.95 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Wolumen Korelacja

Długi: -0.85 (strong negative)

Krótki: 0.87 (strong)

Signal:(60) Same movement expected

Axsome Therapeutics Inc Korelacja

10 Najbardziej pozytywne korelacje
MMAC	0.888
AMGN	0.885
BOCH	0.879
PDCO	0.878
MIRM	0.876
RNEM	0.87
BATRA	0.869
SINO	0.866
BATRK	0.86
VIRI	0.858

10 Najbardziej negatywne korelacje
APOP	-0.937
TDAC	-0.893
MAGS	-0.891
CMLF	-0.868
BHTG	-0.861
VTRU	-0.848
GAINL	-0.847
TRIT	-0.845
RMRM	-0.843
XOG	-0.842

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Axsome Therapeutics Inc Korelacja - Waluta/Towar

-0.24
( neutral )

-0.60
( weak negative )

0.22
( neutral )

0.39
( neutral )

0.47
( neutral )

-0.80
( strong negative )

Axsome Therapeutics Inc Finanse

Annual	2023
Przychody:	$270.60M
Zysk brutto:	$237.70M (87.84 %)
EPS:	$-5.27

FY	2023
Przychody:	$270.60M
Zysk brutto:	$237.70M (87.84 %)
EPS:	$-5.27

FY	2022
Przychody:	$50.04M
Zysk brutto:	$44.84M (89.61 %)
EPS:	$-4.86

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-3.47

Financial Reports:

No articles found.

Axsome Therapeutics Inc

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly absorbed, multi-mechanistic, and investigational medicine that has completed two Phase III trials for the acute treatment of migraine; AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is in Phase III trial to treat narcolepsy; and AXS-14, a novel, oral, and investigational medicine that is in Phase III trial for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.